AD / Sr. AD, Medical Clinical Evidence Implementation Liaison - CRM (Obesity/Liver)

Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

The Clinical Evidence Implementation Liaison, will function as a field-based extension of Medicine serving as the account medical lead working with key decision makers within organized customer organizations including payors, health-systems (IDNs), pharmacy benefit managers, and other organizations providing coordinated, systemic and population-based patient care.  The role provides focused medical support for prioritized therapeutic areas, assets, and organized customer accounts, enabling greater depth of scientific engagement, account insight generation, and implementation science support. 

Beyond scientific exchange, the CEIL partners with the account to diagnose care-delivery gaps along the patient journey, identify implementation opportunities aligned to BI's Implementation Science strategy, and support co-designed, evidence-based interventions that improve diagnosis, guideline-directed treatment adoption, patient outcomes, and health-system performance.  

The CEIL manages a deliberately prioritized portfolio of organized customer accounts, concentrating effort based on TA and asset priorities, account strategic relevance, unmet need, organizational readiness, and the potential for measurable impact. The portfolio may include regional and large regional accounts spanning multiple geographies.  

The CEIL applies independent judgment and established criteria to assess opportunities within the assigned portfolio and identify potential new accounts. The role provides evidence-based recommendations regarding account prioritization and changes in focus to CEIL and TA/CDMA leadership. Material changes to portfolio composition or resource commitments remain subject to established governance. 

The CEIL will have a basic knowledge of implementation-science methodologies and quality-improvement methods to serve as a credible and knowledgeable scientific resource to assigned accounts and account teams.

The CEIL will serve as an account-focused resource who will, in adherence to the principles of scientific exchange, obtain scientific insights driven by approved scientific objectives to inform the strategies and objectives of Medicine. The CEIL operates within the TA/Asset strategy and prioritization, set by CDMA leadership. The CEIL role is essential to ensure that Medicine remains customer focused and considers the needs and focus of the managed markets customer base in developing its medical/scientific strategy. The CEIL monitors relevant healthcare and account trends and provides actionable insights to Medical Affairs Strategy Teams and account partners to inform medical and account planning.

Duties & Responsibilities

The CEIL provides account insights to support the development and refinement of TA account objectives and coordinates with CEIL leadership, TA/CDMA, and relevant account-team partners to support aligned execution. The role identifies qualified account-based investigators and collaborators for potential clinical research, evidence-generation, Implementation Science, and quality-improvement opportunities and communicates these opportunities through established governance processes. 

Multi-stakeholder Engagement, Scientific exchange and account strategy accountability 

Ensure the timely and appropriate delivery of relevant scientific information including scientific data and information on  BI's pipeline or marketed products to key decision makers (KDMs) with the appropriate scientific and operational expertise (scientific, clinical, quality, pharmacy, informatics, care coordination) in identified national and regional accounts. Respond to requests in a manner consistent with applicable compliance guardrails and the principles of scientific exchange.  Build strong and trusted relationships with the medical and scientific leadership at the account by serving as the lead medical point of contact. Lead the development, with input from the BI account team, of the medical/scientific strategy for the parent and/or child account plan; and coordinate seamless execution at affiliated accounts. Develop and enhance knowledge of the customer by working collaboratively with the account team and other customer-facing personnel to provide account and medical market insights and feedback. Identify and deliver meaningful scientific content in response to customer inquiries in alignment with approved TA-specific scientific objectives.

Engage clinicians together with quality leaders, pharmacy, IT/informatics, care coordination, and administrative or executive stakeholders at the account (not solely scientific KDMs) to gather scientific insights representative of account evidence needs, and opportunities to partner in solutions to improve patient care. 

Apply established TA and Medical Engagement criteria to manage and continually optimize a portfolio of organized customers. Independently scan the healthcare landscape and leverage field insights, account data, stakeholder access, unmet need, organizational readiness, and implementation potential to identify existing or new accounts that may advance approved TA and asset objectives. Conduct initial qualification of emerging opportunities and recommend the addition, continuation, escalation, modification, replacement, or deprioritization of accounts and account-level activity. Exercise discretion in allocating time across approved exploratory and assigned account activities; material portfolio changes and commitments of BI resources remain subject to CEIL leadership and TA/CDMA governance. 

Care-gap, patient-journey, and Implementation Science opportunity accountability 

Assess and document account-level barriers across the patient journey, including diagnosis, referral, treatment initiation, escalation, follow-up, and continuity of care. Evaluate relevant workflows, stakeholder alignment, organizational readiness, data availability, and capacity for change. 

Compensation

The base salary range for the Associate Director, CEIL position is $190,500 to $285,700. The base salary range for the Sr. Associate Director, CEIL position is $196,000 to $294,000.The position may be eligible for a role specific discretionary bonus, relocation, and/or other compensation elements. We continuously review market data and may adjust salary ranges as needed in the future. Actual compensation will be based on job-related factors such as skills, experience, and qualifications, and other factors permitted by law.   Benefits include medical, dental and vision coverage, retirement savings opportunities, paid time off, paid holidays, disability and life insurance benefits, and other company-sponsored programs.   For additional information regarding our benefits and Total Rewards offerings, please click here.

Requirements

Associate Director Requirements: 

Master's degree in a scientific discipline required (e. g., MSc.) with a minimum of 5 years in the pharmaceutical/healthcare industry, of which 2 years are in a customer-facing role or in a management / market access role. Doctoral degree preferred (e. g., PharmD, PhD, MD, DO). Bachelor's degree with Healthcare Professional License in a related field (e. g., RPh) with a minimum of 7 years in the pharmaceutical/healthcare industry, including 3 years in a customer-facing role or in a management / market access role. 

Sr. Associate Director Requirements:

Master's degree in a scientific discipline required (e. g., MSc.) with a minimum of 7 years in the pharmaceutical/healthcare industry, of which 4 years are in a customer-facing role or in a management / market access role. Doctoral degree preferred (e. g., PharmD, PhD, MD, DO). Bachelor's degree with Healthcare Professional License in a related field (e. g., RPh) with a minimum of 9 years in the pharmaceutical/healthcare industry, including 3 years in a customer-facing role or in a management / market access role. 

Additional Requirements:

Prior experience in one or more of the following: medical affairs, clinical practice, research, academic or managed healthcare is required. 

Prior medical/scientific field experience required. 

Prior experience interacting with or working within a payer or organized provider highly preferred 

Prior experience working in/across multiple therapeutic areas preferred 

Demonstrated understanding of pharmacoeconomic and health outcomes research principles, disease management principles and tools and EBM strongly preferred 

Demonstrated  understanding in applying Implementation Science, quality-improvement, or healthcare transformation methods to identify care-delivery barriers and support measurable change within complex healthcare organizations. Experience may include workflow assessment, stakeholder and readiness assessment, implementation planning, intervention monitoring, pragmatic evidence generation, or evaluation of adoption, fidelity, feasibility, and sustainability. 

Solid understanding of the healthcare environment and its impact on pharmaceutical companies, payers and organized providers preferred 

Scientific / Clinical Expertise: Demonstration of thorough understanding of disease states, TA portfolio, competitive landscape, and research methodology.  

Customer Engagement: Customer interaction planning, purposeful engagement, providing solutions, addressing perceptions, and confirmation of next steps.  

Identify and conduct initial qualification of organized customer opportunities using established criteria; Provide evidence-based input to account prioritization and resource-allocation decisions. 

Executive Presence / EQ: Presentation and communication skills, situational awareness, emotional resilience, positive image, development and maintenance of relationships.  

Collaboration: Works with FBM peers, partners with cross-functional stakeholders, works well with CDMA and FBM leadership, initiates collaborative relationships that lead to desired outcomes, and connects individual stakeholders with the medical community. 

Accountability: Even in ambiguous circumstances, take ownership for decisions and actions. Demonstrates sound judgment regarding when to act independently and when to escalate. 

Ability and willingness for significant travel.

Ability to use field-based electronic or other communication tools for all aspects of the job 

Eligibility Requirements:

• Must be legally authorized to work in the United States without restriction.
• Must be willing to take a drug test and post-offer physical (if required)
• Must be 18 years of age or older

Desired Skills, Experience and Abilities

Validate local account capabilities, readiness, stakeholder alignment, and data availability at account against approved TA evidence generation priorities. 

Contribute account findings and supporting evidence to opportunity briefs developed with the Implementation Science team and TA/CDMA partners. 

Partner with the Implementation Science team and TA/CDMA leadership to evaluate feasibility, strategic relevance, evidence needs, and suitability for advancement.  

Engage in scientific exchange to understand customer evidence needs, gather feedback and scientific insights that may identify gaps that BI can potentially address through the evidence generation and medical affairs plan. Analyze and assist with reporting scientific insights from assigned/engaged accounts. Assess and understand account strategies for disease management, treatment protocols, and the patient journey. At the direction of CEIL Leadership, share scientific insights from customer interactions with internal stakeholders to inform  commercial and/or clinical development strategies. 

Serve as the account-facing medical lead for the execution of approved Implementation Science interventions. In partnership with the Implementation Science Lead, TA/CDMA, and account stakeholders, support stakeholder alignment, onboarding, workflow integration, implementation monitoring, issue identification, and collection of account-level feedback and data. 

Execute within the approved intervention design, governance, compliance requirements, and measurement plan. Escalate material deviations, barriers, or proposed adaptations to the designated Implementation Science and TA/CDMA decision makers.

Identify appropriate account-based scientists with an interest in and qualifications for conducting or participating in BI-sponsored clinical studies or external collaborative research studies, including implementation-science studies, quality-improvement projects, and learning collaboratives, and communicate this information according to established Medicine or Commercial process and procedures. Gather and interpret the customer's research objectives and communicate with appropriate internal BI personnel. Have a strong working understanding of the Triple Aim and of account drivers and communicate proposed scientific partnership or collaboration opportunities(e. g., traditional/non-traditional research, pragmatic clinical trials, Real World Evidence, IS generation) to appropriate BI personnel consistent with applicable process and procedures. 

Expand BI's understanding of key account drivers, internal workings, and clinical decision-making approaches regarding population health, including interpretation of RWD/RWE, operational metrics, patient-journey data, and baseline capabilities within each account. Communicate insights regarding medically relevant developments within the market landscape to internal stakeholders. Ensure internal stakeholders are aware of customer needs, expectations, and perceptions. Work with other CEILs (beyond assigned accounts) to understand customer macro trends and evaluate whether these may be leveraged across CEIL-assigned accounts.

Continuous learning to maintain a high level of knowledge regarding (a) new scientific developments in our products and TAs of interest, (b) changes within the assigned account that impact BI strategically, and (c) macro trends and changes in the healthcare environment.